SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SNW - FR0000120578 - Common Stock
86.25 EUR
+0.74 (+0.87%)
SNW gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While SNW belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SNW is not valued too expensively and it also shows a decent growth rate. SNW also has an excellent dividend rating. These ratings would make SNW suitable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year SNW was profitable.
In the past year SNW had a positive cash flow from operations.
Each year in the past 5 years SNW has been profitable.
SNW had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 11.05%, SNW is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
SNW has a better Return On Equity (19.73%) than 65.45% of its industry peers.
SNW's Return On Invested Capital of 13.84% is fine compared to the rest of the industry. SNW outperforms 69.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 14.90%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
With a decent Profit Margin value of 20.35%, SNW is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SNW has grown nicely.
SNW has a Operating Margin (23.59%) which is in line with its industry peers.
In the last couple of years the Operating Margin of SNW has grown nicely.
SNW's Gross Margin of 71.70% is in line compared to the rest of the industry. SNW outperforms 50.91% of its industry peers.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNW is creating value.
Compared to 1 year ago, SNW has about the same amount of shares outstanding.
The number of shares outstanding for SNW remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of SNW is 2.21, which is a good value as it means it would take SNW, 2.21 years of fcf income to pay off all of its debts.
SNW has a better Debt to FCF ratio (2.21) than 87.27% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SNW is not too dependend on debt financing.
SNW's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. SNW outperforms 78.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.65%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, SNW perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SNW may have some problems paying its short term obligations.
SNW has a Quick ratio (0.94) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
Looking at the last year, SNW shows a small growth in Revenue. The Revenue has grown by 2.56% in the last year.
SNW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
SNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.11% yearly.
SNW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.55% yearly.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.35, which indicates a very decent valuation of SNW.
Based on the Price/Earnings ratio, SNW is valued cheaper than 81.82% of the companies in the same industry.
SNW is valuated cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.04, which indicates a very decent valuation of SNW.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.45. SNW is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.35 | ||
| Fwd PE | 10.04 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 63.64% of the companies listed in the same industry.
SNW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNW is cheaper than 61.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.8 | ||
| EV/EBITDA | 11.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.7
PEG (5Y)2.23
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
SNW has a Yearly Dividend Yield of 4.59%, which is a nice return.
Compared to an average industry Dividend Yield of 3.00, SNW pays a better dividend. On top of this SNW pays more dividend than 89.09% of the companies listed in the same industry.
SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
34.82% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
FRA:SNW (11/21/2025, 7:00:00 PM)
86.25
+0.74 (+0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap209.50B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target108.63 (25.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.86%
PT rev (3m)-0.1%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.35 | ||
| Fwd PE | 10.04 | ||
| P/S | 3.09 | ||
| P/FCF | 20.8 | ||
| P/OCF | 18.41 | ||
| P/B | 2.99 | ||
| P/tB | 22.54 | ||
| EV/EBITDA | 11.04 |
EPS(TTM)7.6
EY8.81%
EPS(NY)8.59
Fwd EY9.96%
FCF(TTM)4.15
FCFY4.81%
OCF(TTM)4.69
OCFY5.43%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.7
PEG (5Y)2.23
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.65%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.07% in the next year.